The global market for Basic Infusion was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Basic Infusion is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Basic Infusion is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Basic Infusion include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical, Haisco Pharmaceutical Group, King York, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Basic Infusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basic Infusion.
The Basic Infusion market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Basic Infusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Basic Infusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
Segment by Type
Glucose
Sodium Chloride
Compound Product
Segment by Application
max. 100ml
250ml
500ml
min. 1L
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Basic Infusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Basic Infusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Basic Infusion Market Overview
1.1 Product Definition
1.2 Basic Infusion by Type
1.2.1 Global Basic Infusion Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glucose
1.2.3 Sodium Chloride
1.2.4 Compound Product
1.3 Basic Infusion by Application
1.3.1 Global Basic Infusion Market Value by Application (2024 VS 2031)
1.3.2 max. 100ml
1.3.3 250ml
1.3.4 500ml
1.3.5 min. 1L
1.4 Global Basic Infusion Market Size Estimates and Forecasts
1.4.1 Global Basic Infusion Revenue 2020-2031
1.4.2 Global Basic Infusion Sales 2020-2031
1.4.3 Global Basic Infusion Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Basic Infusion Market Competition by Manufacturers
2.1 Global Basic Infusion Sales Market Share by Manufacturers (2020-2025)
2.2 Global Basic Infusion Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Basic Infusion Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Basic Infusion, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Basic Infusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basic Infusion, Product Type & Application
2.7 Global Key Manufacturers of Basic Infusion, Date of Enter into This Industry
2.8 Global Basic Infusion Market Competitive Situation and Trends
2.8.1 Global Basic Infusion Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Basic Infusion Players Market Share by Revenue
2.8.3 Global Basic Infusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Basic Infusion Market Scenario by Region
3.1 Global Basic Infusion Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Basic Infusion Sales by Region: 2020-2031
3.2.1 Global Basic Infusion Sales by Region: 2020-2025
3.2.2 Global Basic Infusion Sales by Region: 2026-2031
3.3 Global Basic Infusion Revenue by Region: 2020-2031
3.3.1 Global Basic Infusion Revenue by Region: 2020-2025
3.3.2 Global Basic Infusion Revenue by Region: 2026-2031
3.4 North America Basic Infusion Market Facts & Figures by Country
3.4.1 North America Basic Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Basic Infusion Sales by Country (2020-2031)
3.4.3 North America Basic Infusion Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basic Infusion Market Facts & Figures by Country
3.5.1 Europe Basic Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Basic Infusion Sales by Country (2020-2031)
3.5.3 Europe Basic Infusion Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basic Infusion Market Facts & Figures by Region
3.6.1 Asia Pacific Basic Infusion Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Basic Infusion Sales by Region (2020-2031)
3.6.3 Asia Pacific Basic Infusion Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basic Infusion Market Facts & Figures by Country
3.7.1 Latin America Basic Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Basic Infusion Sales by Country (2020-2031)
3.7.3 Latin America Basic Infusion Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basic Infusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Basic Infusion Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Basic Infusion Sales by Country (2020-2031)
3.8.3 Middle East and Africa Basic Infusion Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basic Infusion Sales by Type (2020-2031)
4.1.1 Global Basic Infusion Sales by Type (2020-2025)
4.1.2 Global Basic Infusion Sales by Type (2026-2031)
4.1.3 Global Basic Infusion Sales Market Share by Type (2020-2031)
4.2 Global Basic Infusion Revenue by Type (2020-2031)
4.2.1 Global Basic Infusion Revenue by Type (2020-2025)
4.2.2 Global Basic Infusion Revenue by Type (2026-2031)
4.2.3 Global Basic Infusion Revenue Market Share by Type (2020-2031)
4.3 Global Basic Infusion Price by Type (2020-2031)
5 Segment by Application
5.1 Global Basic Infusion Sales by Application (2020-2031)
5.1.1 Global Basic Infusion Sales by Application (2020-2025)
5.1.2 Global Basic Infusion Sales by Application (2026-2031)
5.1.3 Global Basic Infusion Sales Market Share by Application (2020-2031)
5.2 Global Basic Infusion Revenue by Application (2020-2031)
5.2.1 Global Basic Infusion Revenue by Application (2020-2025)
5.2.2 Global Basic Infusion Revenue by Application (2026-2031)
5.2.3 Global Basic Infusion Revenue Market Share by Application (2020-2031)
5.3 Global Basic Infusion Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Basic Infusion Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Company Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.2.4 B. Braun Basic Infusion Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Company Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi Basic Infusion Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Kelun Pharma
6.4.1 Kelun Pharma Company Information
6.4.2 Kelun Pharma Description and Business Overview
6.4.3 Kelun Pharma Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kelun Pharma Basic Infusion Product Portfolio
6.4.5 Kelun Pharma Recent Developments/Updates
6.5 Otsuka Pharmaceutical
6.5.1 Otsuka Pharmaceutical Company Information
6.5.2 Otsuka Pharmaceutical Description and Business Overview
6.5.3 Otsuka Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Otsuka Pharmaceutical Basic Infusion Product Portfolio
6.5.5 Otsuka Pharmaceutical Recent Developments/Updates
6.6 JW Pharmaceutical
6.6.1 JW Pharmaceutical Company Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.6.4 JW Pharmaceutical Basic Infusion Product Portfolio
6.6.5 JW Pharmaceutical Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Basic Infusion Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Company Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teva Pharmaceutical Basic Infusion Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Haisco Pharmaceutical Group
6.9.1 Haisco Pharmaceutical Group Company Information
6.9.2 Haisco Pharmaceutical Group Description and Business Overview
6.9.3 Haisco Pharmaceutical Group Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Haisco Pharmaceutical Group Basic Infusion Product Portfolio
6.9.5 Haisco Pharmaceutical Group Recent Developments/Updates
6.10 King York
6.10.1 King York Company Information
6.10.2 King York Description and Business Overview
6.10.3 King York Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.10.4 King York Basic Infusion Product Portfolio
6.10.5 King York Recent Developments/Updates
6.11 Cisen
6.11.1 Cisen Company Information
6.11.2 Cisen Description and Business Overview
6.11.3 Cisen Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cisen Basic Infusion Product Portfolio
6.11.5 Cisen Recent Developments/Updates
6.12 Lummy
6.12.1 Lummy Company Information
6.12.2 Lummy Description and Business Overview
6.12.3 Lummy Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lummy Basic Infusion Product Portfolio
6.12.5 Lummy Recent Developments/Updates
6.13 Grand Life Sciences
6.13.1 Grand Life Sciences Company Information
6.13.2 Grand Life Sciences Description and Business Overview
6.13.3 Grand Life Sciences Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Grand Life Sciences Basic Infusion Product Portfolio
6.13.5 Grand Life Sciences Recent Developments/Updates
6.14 Medisan
6.14.1 Medisan Company Information
6.14.2 Medisan Description and Business Overview
6.14.3 Medisan Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Medisan Basic Infusion Product Portfolio
6.14.5 Medisan Recent Developments/Updates
6.15 BBCA Pharmaceutical
6.15.1 BBCA Pharmaceutical Company Information
6.15.2 BBCA Pharmaceutical Description and Business Overview
6.15.3 BBCA Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BBCA Pharmaceutical Basic Infusion Product Portfolio
6.15.5 BBCA Pharmaceutical Recent Developments/Updates
6.16 Biokin Pharmaceutical
6.16.1 Biokin Pharmaceutical Company Information
6.16.2 Biokin Pharmaceutical Description and Business Overview
6.16.3 Biokin Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Biokin Pharmaceutical Basic Infusion Product Portfolio
6.16.5 Biokin Pharmaceutical Recent Developments/Updates
6.17 Xi'an Libang Pharmaceutical
6.17.1 Xi'an Libang Pharmaceutical Company Information
6.17.2 Xi'an Libang Pharmaceutical Description and Business Overview
6.17.3 Xi'an Libang Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Xi'an Libang Pharmaceutical Basic Infusion Product Portfolio
6.17.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
6.18 Lionco Pharmaceutical
6.18.1 Lionco Pharmaceutical Company Information
6.18.2 Lionco Pharmaceutical Description and Business Overview
6.18.3 Lionco Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Lionco Pharmaceutical Basic Infusion Product Portfolio
6.18.5 Lionco Pharmaceutical Recent Developments/Updates
6.19 China Meheco Kangli
6.19.1 China Meheco Kangli Company Information
6.19.2 China Meheco Kangli Description and Business Overview
6.19.3 China Meheco Kangli Basic Infusion Sales, Revenue and Gross Margin (2020-2025)
6.19.4 China Meheco Kangli Basic Infusion Product Portfolio
6.19.5 China Meheco Kangli Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basic Infusion Industry Chain Analysis
7.2 Basic Infusion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basic Infusion Production Mode & Process Analysis
7.4 Basic Infusion Sales and Marketing
7.4.1 Basic Infusion Sales Channels
7.4.2 Basic Infusion Distributors
7.5 Basic Infusion Customer Analysis
8 Basic Infusion Market Dynamics
8.1 Basic Infusion Industry Trends
8.2 Basic Infusion Market Drivers
8.3 Basic Infusion Market Challenges
8.4 Basic Infusion Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
听
听
*If Applicable.